Medicenna Therapeutics Corp.
MDNAF
$1.15
$0.054.55%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.46% | -530.64% | 122.30% | -21.46% | -14.87% |
| Total Depreciation and Amortization | 21.90% | 3.79% | 2.33% | 59.26% | 118.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.52% | 100.29% | -748.28% | 420.21% | -191.17% |
| Change in Net Operating Assets | -109.13% | 44.66% | 73.92% | 146.48% | -220.45% |
| Cash from Operations | -39.86% | 26.38% | -37.07% | 38.29% | -141.90% |
| Capital Expenditure | -- | -- | -- | 100.00% | 93.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 93.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -46.15% | 31.58% | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | 89.66% | -95.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -148.94% | 313.64% | -100.97% | 163.33% | -96.61% |
| Foreign Exchange rate Adjustments | 128.26% | -527.62% | -111.54% | 503.25% | -370.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.09% | 11.97% | -1,070.15% | 91.95% | -127.99% |